0

Chiropractic Doctor CE Course - Risk 152 : New Frontiers in Healthcare Liability: AI, Robotics, and Wearables

Chiropractic Doctor


Risk 152 : New Frontiers in Healthcare Liability: AI, Robotics, and Wearables
2.0

Peter Van Tyle, Esq

$40.00 USD

AudioVisual Course


Hour 1

  • Analyze ethical and legal challenges where human healthcare professional judgment diverges from that of deep learning medical hardware, and employment of “off label” use of AI-assisted devices.
  • Evaluate "Black Box" and “hallucination” liability dilemmas in AI-assisted healthcare, outlining parties’ accountability for AI error.
  • Explain the foundational risk of algorithmic bias, using the "Garbage In, Garbage Out" principle to describe its impact on AI effectiveness in healthcare.
  • Distinguish between fixed and continuously-learning algorithms, how the FDA treats them for purposes of healthcare device approval, and the effect on professionals’ liability.
  • Contrast consumer data protection provided by the FTC with the patient-data protection by HIPAA, and explain the "Privacy Gap" for consumer health devices.

 Hour 2

  • Differentiate the roles of international bodies (like ISO) and U.S. national agencies (like NIST) in creating safe AI standards.
  • Evaluate legal precedents (such as the Washington teeth whitening case) and discuss why a professional is held to a higher legal standard of care than a layperson, even when performing the same task, and the importance of preventing "public confusion" regarding those standards.
  • Explain how the FDA’s rigorous approval process for diagnostic devices serves to "supplant" or "substitute" for the individual judgment of a licensed healthcare professional.
  • Identify the three core elements that generally constitute the practice of medicine under U.S. state laws and discuss the public safety risks that occur when a patient receives an accurate diagnosis from a machine but lacks the counseling or context provided by a human professional.
  • Explain the economic and regulatory incentives for AI manufacturers to move operations to countries with less rigorous approval processes to provide "life-saving" care to international consumers.

Approved States/Territories
  • AKAlaska
  • BCBritish Columbia
  • COColorado
  • CTConnecticut
  • DEDelaware
  • DCDistrict of Columbia
  • GAGeorgia
  • GUGuam
  • IDIdaho
  • ILIllinois
  • INIndiana
  • IAIowa
  • KSKansas
  • MEMaine
  • MBManitoba
  • MDMaryland
  • MAMassachusetts
  • MIMichigan
  • MNMinnesota
  • MOMissouri
  • MTMontana
  • NENebraska
  • NBNew Brunswick
  • NHNew Hampshire
  • NJNew Jersey
  • NYNew York
  • NCNorth Carolina
  • NDNorth Dakota
  • NSNova Scotia
  • OHOhio
  • ONOntario
  • OROregon
  • PRPuerto Rico
  • RIRhode Island
  • SCSouth Carolina
  • SDSouth Dakota
  • TNTennessee
  • UTUtah
  • VTVermont
  • VIVirgin Islands
  • VAVirginia
  • WAWashington
  • WYWyoming
  • YTYukon